×

Tag: Drug Discovery

Insilico Medicine
In a new paper, InSilico has reported on its impressive success with a drug against idiopathic pulmonary fibrosis that was created by AI “from A to Z” and is currently in Phase 2 trials [1]. AI against aging Many people in the longevity community hope that the might of AI will help us to untangle...
Two apples one arrow
A new study published in Aging Cell applied an artificial intelligence target discovery platform to aid in identifying potential dual-purpose targets for anti-aging and anti-cancer treatments [1]. Killing two birds with one stone Aging, as is the case with many diseases, is a risk factor for cancer, and the processes behind aging and cancer are...
Kelsey Moody
Today, we are speaking to Ichor Life Sciences CEO Dr. Kelsey Moody about the doctoral program that the company operates and how the company is supporting the next generation of scientists. Ichor Life Sciences is a biotechnology company that develops and manufactures new medicines for people around the world. It is focused on creating treatments...
AI drug discovery
Research published today in Nature Aging has described a machine learning algorithm that finds senescent cell-removing drugs (senolytics) and compared the algorithm's discoveries to existing compounds. A quest for effective therapeutics What Are Senolytics? Senotherapeutics for Senescent CellsSenolytics work by targeting one of several pro-survival pathways that senescent cells use to evade apoptosis and cling...
Stephanie Dainow ARDD
On August 22, 2022, Lifespan.io Executive Director Stephanie Dainow will participate in the Decentralized Science and Blockchain session as a part of the Emerging Tech Workshop at the world’s largest annual Aging Research and Drug Discovery conference (9th ARDD). Stephanie Dainow is the Executive Director at Lifespan.io. Stephanie Dainow has a lifelong passion for longevity...
AI Drug Discovery
A new study conducted by Insilico Medicine in collaboration with leading aging research institutions has identified novel therapeutic targets for amyotrophic lateral sclerosis, a devastating age-associated neurodegenerative disease [1]. Disease and aging: not that different Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease. It is most famous for afflicting the well-known physicist Stephen Hawking,...